We deliver strategic forecasts that adapt to evolving product profiles and ever-changing market landscapes.
Substantial R&D investments must be predicated on comprehensive, dynamic, and clear forecasts that can help justify clinical study design in the earliest phases and guide commercial strategy all the way through a successful launch.

Reliable, dynamic models that can anticipate product and market changes are required from the outset. Precision forecasts must integrate and calibrate disparate sets of data and research to accurately project your product’s uptake. We’ll work collaboratively with your internal stakeholders to identify the most important variables and forecast drivers for your model.

At Viscadia, we design and build sophisticated models to give you the highest levels of clarity and confidence — no matter what future timeframe you are looking at.

Our models identify, calibrate and incorporate other critical variables that will impact both uptake and revenue, including detailed epidemiology assessments, patient persistence and compliance, harmonization across indications and geographies and therapeutic segmentation. We also build our models to allow seamless transition from the pipeline phase through launch and into on-market application, eliminating the need to develop a separate on-market forecasting tool.

Designed and built global model for complex oncology condition

View Case Study